Conducting a critical interpretive synthesis of the literature on access to healthcare by vulnerable groups M Dixon-Woods, D Cavers, S Agarwal, E Annandale, A Arthur, J Harvey, ... BMC medical research methodology 6 (1), 1-13, 2006 | 1359 | 2006 |
Interpretation of random effects meta-analyses RD Riley, JPT Higgins, JJ Deeks Bmj 342, 2011 | 1292 | 2011 |
Meta-analysis of individual participant data: rationale, conduct, and reporting RD Riley, PC Lambert, G Abo-Zaid Bmj 340, c221, 2010 | 1115 | 2010 |
Preferred reporting items for a systematic review and meta-analysis of individual participant data: the PRISMA-IPD statement LA Stewart, M Clarke, M Rovers, RD Riley, M Simmonds, G Stewart, ... Jama 313 (16), 1657-1665, 2015 | 803 | 2015 |
Prognosis Research Strategy (PROGRESS) 3: prognostic model research EW Steyerberg, KGM Moons, DA van der Windt, JA Hayden, P Perel, ... PLoS Med 10 (2), e1001381, 2013 | 754 | 2013 |
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal L Wynants, B Van Calster, GS Collins, RD Riley, G Heinze, E Schuit, ... bmj 369, 2020 | 697 | 2020 |
Prognosis Research Strategy (PROGRESS) 2: prognostic factor research RD Riley, JA Hayden, EW Steyerberg, KGM Moons, K Abrams, PA Kyzas, ... PLoS Med 10 (2), e1001380, 2013 | 430 | 2013 |
Quantifying the impact of between‐study heterogeneity in multivariate meta‐analyses D Jackson, IR White, RD Riley Statistics in medicine 31 (29), 3805-3820, 2012 | 401 | 2012 |
Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes H Hemingway, P Croft, P Perel, JA Hayden, K Abrams, A Timmis, A Briggs, ... Bmj 346, 2013 | 371 | 2013 |
Multivariate meta‐analysis: potential and promise D Jackson, R Riley, IR White Statistics in medicine 30 (20), 2481-2498, 2011 | 363 | 2011 |
Prognosis research strategy (PROGRESS) 4: stratified medicine research AD Hingorani, DA van der Windt, RD Riley, K Abrams, KGM Moons, ... Bmj 346, e5793, 2013 | 339 | 2013 |
Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey I Ahmed, AJ Sutton, RD Riley Bmj 344, d7762, 2012 | 304 | 2012 |
Risk of late relapse or reinfection with hepatitis C virus after achieving a sustained virological response: a systematic review and meta-analysis B Simmons, J Saleem, A Hill, RD Riley, GS Cooke Clinical Infectious Diseases 62 (6), 683-694, 2016 | 241 | 2016 |
Meta‐analysis of continuous outcomes combining individual patient data and aggregate data RD Riley, PC Lambert, JA Staessen, J Wang, F Gueyffier, L Thijs, ... Statistics in medicine 27 (11), 1870-1893, 2008 | 233 | 2008 |
A systematic review of molecular and biological tumor markers in neuroblastoma RD Riley, D Heney, DR Jones, AJ Sutton, PC Lambert, KR Abrams, ... Clinical Cancer Research 10 (1), 4-12, 2004 | 227 | 2004 |
External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges RD Riley, J Ensor, KIE Snell, TPA Debray, DG Altman, KGM Moons, ... bmj 353, i3140, 2016 | 217 | 2016 |
Bivariate random-effects meta-analysis and the estimation of between-study correlation RD Riley, KR Abrams, AJ Sutton, PC Lambert, JR Thompson BMC Medical Research Methodology 7 (1), 3, 2007 | 212 | 2007 |
PROBAST: a tool to assess the risk of bias and applicability of prediction model studies RF Wolff, KGM Moons, RD Riley, PF Whiting, M Westwood, GS Collins, ... Annals of internal medicine 170 (1), 51-58, 2019 | 196 | 2019 |
An evaluation of bivariate random‐effects meta‐analysis for the joint synthesis of two correlated outcomes RD Riley, KR Abrams, PC Lambert, AJ Sutton, JR Thompson Statistics in medicine 26 (1), 78-97, 2007 | 184 | 2007 |
Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods RD Riley, MC Simmonds, MP Look Journal of clinical epidemiology 60 (5), 431. e1-431. e12, 2007 | 183 | 2007 |